FOLVERLAN 0.4 mg tablets, 100 pcs

Instructions for use for FOLVERLAN 0.4 mg tablets, 100 pcs

Detailed instructions for FOLVERLAN 0.4 mg tablets, 100 pcs

Field of use

• The medicine is a means of preventing anemia and preventing neural tube defects in newborns
• The medicine is used for:
  • Prevention of folic acid deficits if sufficient folic acid intake with food is not possible.
  • Prevention of neural tube defects in newborns by preventing the treatment of women before occurring and during pregnancy. The use of folic acid is also indicated in full diet.

Active ingredients / ingredients / ingredients

0.4 mg folic acid
Carboxymethylar, sodium salt auxiliary material (+)
Cellulose, microcrystalline auxiliary material (+)
Lactose 1-water auxiliary substance (+)
39.5 mg lactose auxiliary material (+)
Magnesium stair auxiliary material (+)
Silicium dioxide, high disperser auxiliary substance (+)
Strength, pre -clerked auxiliary substance (+)

Contradictions

• The medicine must not be taken,
  • if they are hypersensitive to folic acid or one of the other components of the medicine.
  • if you suffer from a megaloblastary anemia as a result of a vitamin B12 deficiency, without a vitamin B12 treatment.
  • if you suffer from a megaloblastary anemia of unclear cause as long as a vitamin B12 deficiency is not excluded.

dosage

• Always take the medicine exactly according to the doctor's instructions. Please ask your doctor or pharmacist if you are not quite sure.
• Unless otherwise prescribed by the doctor, the usual dose is
  • Prevention of folic acid deficiency: a tablet daily (corresponding to 0.4 mg folic acid). On medical advice, the dose on two tablets can be increased daily (corresponding to 0.8 mg folic acid).
  • Prevention of neural tube defects in newborns: It is recommended that pregnant women and women with desire to have children take a tablet daily (corresponding to 0.4 mg folic acid). On medical advice, this dose on two tablets can be increased daily (corresponding to 0.8 mg folic acid).

 

• Duration of the application:
  • Prevention of folic acid deficiency: The treating doctor decides on the duration of the application.
  • Prevention of neural tube defects in newborns: It is important that you start taking the tablets before pregnancy occurs (preferably four weeks before). After that, the treatment is to be continued over the first 12 weeks of pregnancy.
  • Please speak to your doctor or pharmacist if you have the impression that the effect of the medicine is too strong or too weak.

 

• If you have taken a larger amount of the medicine than you should:
  • If the higher dosage occasionally, no overdose symptoms can be expected.
  • In patients with seizures, however, there may be an increase in willingness to seize.
  • With high doses (over 15 mg per day and longer than four weeks), gastrointestinal disorders, sleep disorders, excitement and depression can occur. In these cases you should contact your doctor.

 

• If you forgot to take the medicine:
  • Do not take the double dose if you have forgotten the prior intake, but continue taking the tablets normally.

 

• If you stop taking the medicine:
  • Before you want to finish taking the tablets on your own, talk to your doctor about it. To prevent neural tube defects in Neueborenen is required to take continuous intake.

 

• If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

• The tablets are taken with sufficient liquid for meals.

Patient information

• Particular caution when taking the medicine is required,
  • if there is a risk of megaloblastary anemia due to a vitamin B12 deficiency. Folic acid can cover a vitamin B12 deficiency. In the case of an unexpected progressive megaloblastary anemia, there is a risk of permanent damage to the nervous system.

 

• Wateriness and operating machines:
  • There are no effects on impairing the traffic and operating of machines.

Pregnancy

• Pregnancy and breast feeding period:
  • No risks are known.

 

Hints

Manufacturer:  Verla-Pharm Arzneimittel GmbH & , Hauptstraße 98, 82327 Tutzing